Global (United States, European Union and China) Biosimilars Market Research Report 2019-2025

Publisher Name :
Date: 04-Jun-2019
No. of pages: 110
Inquire Before Buying

In 2019, the market size of Biosimilars is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.

In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Biosimilars.

This report studies the global market size of Biosimilars, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).

This study presents the Biosimilars sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.

For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:

- Pfizer

- Sandoz International GmbH

- Teva Pharmaceuticals Industries

- Amgen Inc

- Biocon

- Dr. Reddy's Laboratories

- F. Hoffmann-La Roche

- Celltrion

- Samsung Bioepis

Market Segment by Product Type

- Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon)

- Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin)

- Peptides (Glucagon, Calcitonin)

Market Segment by Application

- Oncology

- Blood Disorders

Key Regions split in this report: breakdown data for each region.

- United States

- China

- European Union

- Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:

- To analyze and research the Biosimilars status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.

- To present the key Biosimilars manufacturers, presenting the sales, revenue, market share, and recent development for key players.

- To split the breakdown data by regions, type, companies and applications

- To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.

- To identify significant trends, drivers, influence factors in global and regions

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Biosimilars are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

Global (United States, European Union and China) Biosimilars Market Research Report 2019-2025

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Biosimilars Market Size Growth Rate by Type (2019-2025)
1.3.2 Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon)
1.3.3 Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin)
1.3.4 Peptides (Glucagon, Calcitonin)
1.4 Market Segment by Application
1.4.1 Global Biosimilars Market Share by Application (2019-2025)
1.4.2 Oncology
1.4.3 Blood Disorders
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biosimilars Market Size
2.1.1 Global Biosimilars Revenue 2014-2025
2.1.2 Global Biosimilars Sales 2014-2025
2.2 Biosimilars Growth Rate by Regions
2.2.1 Global Biosimilars Sales by Regions 2014-2019
2.2.2 Global Biosimilars Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Biosimilars Sales by Manufacturers
3.1.1 Biosimilars Sales by Manufacturers 2014-2019
3.1.2 Biosimilars Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Biosimilars Revenue by Manufacturers (2014-2019)
3.2.2 Biosimilars Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Biosimilars Market Concentration Ratio (CR5 and HHI)
3.3 Biosimilars Price by Manufacturers
3.4 Key Manufacturers Biosimilars Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Biosimilars Market
3.6 Key Manufacturers Biosimilars Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) Sales and Revenue (2014-2019)
4.1.2 Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin) Sales and Revenue (2014-2019)
4.1.3 Peptides (Glucagon, Calcitonin) Sales and Revenue (2014-2019)
4.2 Global Biosimilars Sales Market Share by Type
4.3 Global Biosimilars Revenue Market Share by Type
4.4 Biosimilars Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Biosimilars Sales by Application
6 United States
6.1 United States Biosimilars Breakdown Data by Company
6.2 United States Biosimilars Breakdown Data by Type
6.3 United States Biosimilars Breakdown Data by Application
7 European Union
7.1 European Union Biosimilars Breakdown Data by Company
7.2 European Union Biosimilars Breakdown Data by Type
7.3 European Union Biosimilars Breakdown Data by Application
8 China
8.1 China Biosimilars Breakdown Data by Company
8.2 China Biosimilars Breakdown Data by Type
8.3 China Biosimilars Breakdown Data by Application
9 Rest of World
9.1 Rest of World Biosimilars Breakdown Data by Company
9.2 Rest of World Biosimilars Breakdown Data by Type
9.3 Rest of World Biosimilars Breakdown Data by Application
9.4 Rest of World Biosimilars Breakdown Data by Countries
9.4.1 Rest of World Biosimilars Sales by Countries
9.4.2 Rest of World Biosimilars Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Pfizer
10.1.1 Pfizer Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Biosimilars
10.1.4 Biosimilars Product Introduction
10.1.5 Pfizer Recent Development
10.2 Sandoz International GmbH
10.2.1 Sandoz International GmbH Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Biosimilars
10.2.4 Biosimilars Product Introduction
10.2.5 Sandoz International GmbH Recent Development
10.3 Teva Pharmaceuticals Industries
10.3.1 Teva Pharmaceuticals Industries Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Biosimilars
10.3.4 Biosimilars Product Introduction
10.3.5 Teva Pharmaceuticals Industries Recent Development
10.4 Amgen Inc
10.4.1 Amgen Inc Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Biosimilars
10.4.4 Biosimilars Product Introduction
10.4.5 Amgen Inc Recent Development
10.5 Biocon
10.5.1 Biocon Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Biosimilars
10.5.4 Biosimilars Product Introduction
10.5.5 Biocon Recent Development
10.6 Dr. Reddy's Laboratories
10.6.1 Dr. Reddy's Laboratories Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Biosimilars
10.6.4 Biosimilars Product Introduction
10.6.5 Dr. Reddy's Laboratories Recent Development
10.7 F. Hoffmann-La Roche
10.7.1 F. Hoffmann-La Roche Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Biosimilars
10.7.4 Biosimilars Product Introduction
10.7.5 F. Hoffmann-La Roche Recent Development
10.8 Celltrion
10.8.1 Celltrion Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Biosimilars
10.8.4 Biosimilars Product Introduction
10.8.5 Celltrion Recent Development
10.9 Samsung Bioepis
10.9.1 Samsung Bioepis Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Biosimilars
10.9.4 Biosimilars Product Introduction
10.9.5 Samsung Bioepis Recent Development
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Biosimilars Sales Channels
11.2.2 Biosimilars Distributors
11.3 Biosimilars Customers
12 Market Forecast
12.1 Global Biosimilars Sales and Revenue Forecast 2019-2025
12.2 Global Biosimilars Sales Forecast by Type
12.3 Global Biosimilars Sales Forecast by Application
12.4 Biosimilars Forecast by Regions
12.4.1 Global Biosimilars Sales Forecast by Regions 2019-2025
12.4.2 Global Biosimilars Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables and Figures
Figure Biosimilars Product Picture
Table Biosimilars Key Market Segments
Table Major Manufacturers Biosimilars Covered in This Report
Table Global Biosimilars Market Size Growth Rate by Type 2019-2025 (K MT) & (Million US$)
Figure Global Biosimilars Sales Market Shar by Type 2014-2025
Figure Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) Figures
Table Major Manufacturers of Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon)
Figure Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin) Figures
Table Major Manufacturers of Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin)
Figure Peptides (Glucagon, Calcitonin) Figures
Table Major Manufacturers of Peptides (Glucagon, Calcitonin)
Table Global Biosimilars Market Share by Application 2019-2025 (K MT)
Figure Oncology Use Case
Figure Blood Disorders Use Case
Figure Biosimilars Report Years Considered
Figure Global Biosimilars Market Size 2014-2025 (Million US$)
Figure Global Biosimilars Sales 2014-2019 (K MT)
Table Global Biosimilars Market Size by Regions 2014-2019 (K MT) & (Million US$)
Table Global Biosimilars Sales by Regions 2014-2019 (K MT)
Table Global Biosimilars Sales Market Share by Regions 2014-2019
Figure Global Biosimilars Sales Market Share by Regions 2014-2019
Figure Global Biosimilars Sales Market Share by Regions in 2019
Table Global Biosimilars Revenue by Regions 2014-2019 (Million US$)
Table Global Biosimilars Revenue Market Share by Regions 2014-2019
Figure Global Biosimilars Revenue Market Share by Regions 2014-2019
Figure Global Biosimilars Revenue Market Share by Regions in 2019
Table Market Top Trends
Table Global Biosimilars Sales by Manufacturers (2014-2019) (K MT)
Table Global Biosimilars Sales Share by Manufacturers (2014-2019)
Figure Global Biosimilars Sales Share by Manufacturers in 2019
Table Biosimilars Revenue by Manufacturers (2014-2019) (Million USD)
Table Biosimilars Revenue Share by Manufacturers (2014-2019)
Figure Biosimilars Value Share by Manufacturers in 2019
Table Global Biosimilars Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Biosimilars Price (2014-2019) (USD/MT)
Table Key Manufacturers Biosimilars Plants/Factories Distribution
Table Key Manufacturers Biosimilars Area Served
Table Date of Key Manufacturers Enter into Biosimilars Market
Table Key Manufacturers Biosimilars Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon) Sales and Revenue (2014-2019) (K MT) & (Million US$)
Table Global Glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin) Sales and Revenue (2014-2019) (K MT) & (Million US$)
Table Global Peptides (Glucagon, Calcitonin) Sales and Revenue (2014-2019) (K MT) & (Million US$)
Table Global Biosimilars Sales by Type (2014-2019) (K MT)
Table Global Biosimilars Sales Share by Type (2014-2019)
Figure Global Biosimilars Sales Market Share by Type (2014-2019)
Figure Global Biosimilars Sales Market Share by Type in 2018
Table Global Biosimilars Revenue by Type (2014-2019) (Million US$)
Table Global Biosimilars Revenue Share by Type (2014-2019)
Figure Global Biosimilars Revenue Market Share by Type (2014-2019)
Figure Global Biosimilars Revenue Market Share by Type in 2018
Table Biosimilars Price by Type 2014-2019 (USD/MT)
Table Global Biosimilars Sales by Application (2014-2019) (K MT)
Table Global Biosimilars Sales Share by Application (2014-2019)
Figure Global Sales Biosimilars Market Share by Application (2014-2019)
Figure Global Sales Biosimilars Market Share by Application (2014-2019)
Figure United States Biosimilars Sales Growth Rate 2014-2019 (K MT)
Figure United States Biosimilars Revenue Growth Rate 2014-2019 (Million US$)
Table United States Biosimilars Sales by Company (2014-2019) (K MT)
Table United States Biosimilars Sales Market Share by Company (2014-2019)
Figure United States Biosimilars Sales Market Share by Company in 2019
Table United States Biosimilars Sales by Type (2014-2019) (K MT)
Table United States Biosimilars Sales Market Share by Type (2014-2019)
Figure United States Biosimilars Market Share by Type in 2019
Table United States Biosimilars Sales by Application (2014-2019) (K MT)
Table United States Biosimilars Sales Market Share by Application (2014-2019)
Figure United States Biosimilars Market Share by Application in 2019
Figure European Union Biosimilars Sales Growth Rate 2014-2019 (K MT)
Figure European Union Biosimilars Revenue Growth Rate 2014-2019 (Million US$)
Table European Union Biosimilars Sales by Company (2014-2019) (K MT)
Table European Union Biosimilars Sales Market Share by Company (2014-2019)
Figure European Union Biosimilars Sales Market Share by Company in 2019
Table European Union Biosimilars Sales by Type (2014-2019) (K MT)
Table European Union Biosimilars Sales Market Share by Type (2014-2019)
Figure 2018 European Union Biosimilars Market Share by Type
Table European Union Biosimilars Sales by Application (2014-2019) (K MT)
Table European Union Biosimilars Sales Market Share by Application (2014-2019)
Figure 2018 European Union Biosimilars Market Share by Application
Figure China Biosimilars Sales Growth Rate 2014-2019 (K MT)
Figure China Biosimilars Revenue Growth Rate 2014-2019 (Million US$)
Table China Biosimilars Sales by Company (2014-2019) (K MT)
Table China Biosimilars Sales Market Share by Company (2014-2019)
Figure China Biosimilars Sales Market Share by Company in 2019
Table China Biosimilars Sales by Type (2014-2019) (K MT)
Table China Biosimilars Sales Market Share by Type (2014-2019)
Figure China Biosimilars Market Share by Type in 2019
Table China Biosimilars Sales by Application (2014-2019) (K MT)
Table China Biosimilars Sales Market Share by Application (2014-2019)
Figure China Biosimilars Market Share by Application in 2019
Figure Rest of World Biosimilars Sales Growth Rate 2014-2019 (K MT)
Figure Rest of World Biosimilars Revenue Growth Rate 2014-2019 (Million US$)
Table Rest of World Biosimilars Sales by Company (2014-2019) (K MT)
Table Rest of World Biosimilars Sales Market Share by Company (2014-2019)
Figure Rest of World Biosimilars Sales Market Share by Company in 2019
Table Rest of World Biosimilars Sales by Type (2014-2019) (K MT)
Table Rest of World Biosimilars Sales Market Share by Type (2014-2019)
Figure Rest of World Biosimilars Market Share by Type in 2019
Table Rest of World Biosimilars Sales by Application (2014-2019) (K MT)
Table Rest of World Biosimilars Sales Market Share by Application (2014-2019)
Figure Rest of World Biosimilars Market Share by Application in 2019
Table Rest of World Biosimilars Sales by Countries (2014-2019) (K MT)
Table Rest of World Biosimilars Sales Market Share by Countries (2014-2019)
Figure Rest of World Biosimilars Sales Market Share by Countries in 2019
Table Rest of World Biosimilars Revenue by Countries (2014-2019) (Million US$)
Table Rest of World Biosimilars Revenue Market Share by Countries (2014-2019)
Figure Rest of World Biosimilars Revenue Market Share by Countries in 2019
Figure Japan Biosimilars Sales Growth Rate (2014-2019) (K MT)
Figure Japan Biosimilars Revenue Growth Rate (2014-2019) (K MT)
Figure Korea Biosimilars Sales Growth Rate (2014-2019) (K MT)
Figure Korea Biosimilars Revenue Growth Rate (2014-2019) (K MT)
Figure India Biosimilars Sales Growth Rate (2014-2019) (K MT)
Figure India Biosimilars Revenue Growth Rate (2014-2019) (K MT)
Figure Southeast Asia Biosimilars Sales Growth Rate (2014-2019) (K MT)
Figure Southeast Asia Biosimilars Revenue Growth Rate (2014-2019) (K MT)
Table Pfizer Company Details
Table Pfizer Description and Business Overview
Table Pfizer Biosimilars Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Table Pfizer Biosimilars Sales Growth Rate (2014-2019)
Table Pfizer Biosimilars Sales Market Share in Global Market
Table Pfizer Recent Development
Table Sandoz International GmbH Company Details
Table Sandoz International GmbH Description and Business Overview
Table Sandoz International GmbH Biosimilars Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Table Sandoz International GmbH Biosimilars Sales Growth Rate (2014-2019)
Table Sandoz International GmbH Biosimilars Sales Market Share in Global Market
Table Sandoz International GmbH Recent Development
Table Teva Pharmaceuticals Industries Company Details
Table Teva Pharmaceuticals Industries Description and Business Overview
Table Teva Pharmaceuticals Industries Biosimilars Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Table Teva Pharmaceuticals Industries Biosimilars Sales Growth Rate (2014-2019)
Table Teva Pharmaceuticals Industries Biosimilars Sales Market Share in Global Market
Table Teva Pharmaceuticals Industries Recent Development
Table Amgen Inc Company Details
Table Amgen Inc Description and Business Overview
Table Amgen Inc Biosimilars Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Table Amgen Inc Biosimilars Sales Growth Rate (2014-2019)
Table Amgen Inc Biosimilars Sales Market Share in Global Market
Table Amgen Inc Recent Development
Table Biocon Company Details
Table Biocon Description and Business Overview
Table Biocon Biosimilars Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Table Biocon Biosimilars Sales Growth Rate (2014-2019)
Table Biocon Biosimilars Sales Market Share in Global Market
Table Biocon Recent Development
Table Dr. Reddy's Laboratories Company Details
Table Dr. Reddy's Laboratories Description and Business Overview
Table Dr. Reddy's Laboratories Biosimilars Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Table Dr. Reddy's Laboratories Biosimilars Sales Growth Rate (2014-2019)
Table Dr. Reddy's Laboratories Biosimilars Sales Market Share in Global Market
Table Dr. Reddy's Laboratories Recent Development
Table F. Hoffmann-La Roche Company Details
Table F. Hoffmann-La Roche Description and Business Overview
Table F. Hoffmann-La Roche Biosimilars Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Table F. Hoffmann-La Roche Biosimilars Sales Growth Rate (2014-2019)
Table F. Hoffmann-La Roche Biosimilars Sales Market Share in Global Market
Table F. Hoffmann-La Roche Recent Development
Table Celltrion Company Details
Table Celltrion Description and Business Overview
Table Celltrion Biosimilars Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Table Celltrion Biosimilars Sales Growth Rate (2014-2019)
Table Celltrion Biosimilars Sales Market Share in Global Market
Table Celltrion Recent Development
Table Samsung Bioepis Company Details
Table Samsung Bioepis Description and Business Overview
Table Samsung Bioepis Biosimilars Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Table Samsung Bioepis Biosimilars Sales Growth Rate (2014-2019)
Table Samsung Bioepis Biosimilars Sales Market Share in Global Market
Table Samsung Bioepis Recent Development
Figure Biosimilars Value Chain
Table Biosimilars Distributors List
Table Biosimilars Customers List
Table Global Biosimilars Sales Forecast 2019-2025 (K MT) & (Million US$)
Figure Global Biosimilars Sales Forecast 2019-2025 (K MT)
Figure Global Biosimilars Revenue Forecast 2019-2025 (Million US$)
Table Global Biosimilars Sales Forecast by Type 2019-2025 (K MT)
Figure Global Biosimilars Sales Forecast by Type 2019-2025 (K MT)
Figure Global Biosimilars Sales Market Share Forecast by Type 2019-2025
Table Global Biosimilars Sales Forecast by Application 2019-2025 (K MT)
Figure Global Biosimilars Sales Forecast by Application 2019-2025 (K MT)
Figure Global Biosimilars Sales Market Share Forecast by Application 2019-2025
Table Global Biosimilars Sales Forecast by Regions 2019-2025 (K MT)
Figure Global Biosimilars Sales Forecast by Regions 2019-2025 (K MT)
Figure Global Biosimilars Sales Market Share Forecast by Regions 2019-2025
Table Global Biosimilars Revenue Forecast by Regions 2019-2025 (K MT)
Figure Global Biosimilars Revenue Forecast by Regions 2019-2025 (K MT)
Figure Global Biosimilars Revenue Market Share Forecast by Regions 2019-2025
Figure United States Biosimilars Sales Forecast 2019-2025 (K MT)
Figure United States Biosimilars Revenue Forecast 2019-2025 (Million US$)
Figure European Union Biosimilars Sales Forecast 2019-2025 (K MT)
Figure European Union Biosimilars Revenue Forecast 2019-2025 (Million US$)
Figure China Biosimilars Sales Forecast 2019-2025 (K MT)
Figure China Biosimilars Revenue Forecast 2019-2025 (Million US$)
Figure Japan Biosimilars Sales Forecast 2019-2025 (K MT)
Figure Japan Biosimilars Revenue Forecast 2019-2025 (Million US$)
Figure Korea Biosimilars Sales Forecast 2019-2025 (K MT)
Figure Korea Biosimilars Revenue Forecast 2019-2025 (Million US$)
Figure India Biosimilars Sales Forecast 2019-2025 (K MT)
Figure India Biosimilars Revenue Forecast 2019-2025 (Million US$)
Figure Southeast Asia Biosimilars Sales Forecast 2019-2025 (K MT)
Figure Southeast Asia Biosimilars Revenue Forecast 2019-2025 (Million US$)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Biologics and Biosimilars Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 147
    According to our LPI (LP Information) latest study, the global Biologics and Biosimilars market size was valued at US$ 458090 million in 2023. With growing demand in downstream market, the Biologics and Biosimilars is forecast to a readjusted size of US$ 837640 million by 2030 with a CAGR of 9.0% during review period. The research report highlights the growth potential of the global Biologics and Biosimilars market. Biologics and Biosimilars are expected to show stable growth in the futu......
  • Global Biosimilar Drug Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94
    According to our LPI (LP Information) latest study, the global Biosimilar Drug market size was valued at US$ million in 2023. With growing demand in downstream market, the Biosimilar Drug is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Biosimilar Drug market. Biosimilar Drug are expected to show stable growth in the future market. However, product differentiation, reducing cost......
  • Global Biologics and Biosimilars Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 147
    According to our (Global Info Research) latest study, the global Biologics and Biosimilars market size was valued at USD 481830 million in 2023 and is forecast to a readjusted size of USD 842330 million by 2030 with a CAGR of 8.3% during review period. Biologics are very specific, highly effective medicines made in living cells, and historically this was often an animal. Biologics include hormones, cytokines, growth factors, vaccines, gene and cellular therapies, fusion proteins, insulin......
  • Global Biosimilars Market Research Report 2023, Forecast to 2028
    Published: 27-Dec-2023        Price: US 2680 Onwards        Pages: 167
    A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine'). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......
  • Global Biosimilars Professional Survey Report 2023, Forecast to 2028
    Published: 27-Dec-2023        Price: US 3280 Onwards        Pages: 133
    A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine'). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......
  • Global Biosimilars Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 07-Dec-2023        Price: US 3380 Onwards        Pages: 106
    Market Overview of Global Biosimilars market: According to our latest research, the global Biosimilars market looks promising in the next 5 years. As of 2022, the global Biosimilars market was estimated at USD 8203.97 million, and it's anticipated to reach USD 40650.01 million in 2028, with a CAGR of 30.57% during the forecast years. A biosimilar product is a biologic product that is approved based on demonstrating that it is highly similar to an FDA?approved biologic product......
  • Global Biologics and Biosimilars Professional Survey Report 2023, Forecast to 2028
    Published: 24-Nov-2023        Price: US 3280 Onwards        Pages: 134
    Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......
  • Global Biologics and Biosimilars Market Research Report 2023, Forecast to 2028
    Published: 24-Nov-2023        Price: US 2680 Onwards        Pages: 160
    Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......
  • Global Biosimilar Monoclonal Antibodies Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 16-Nov-2023        Price: US 3380 Onwards        Pages: 103
    Market Overview of Global Biosimilar Monoclonal Antibodies market: According to our latest research, the global Biosimilar Monoclonal Antibodies market looks promising in the next 5 years. As of 2022, the global Biosimilar Monoclonal Antibodies market was estimated at USD 5156.19 million, and it's anticipated to reach USD 14274.14 million in 2028, with a CAGR of 18.5% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs